Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag was updated to v3.6.6, replacing the previous v3.6.5. This indicates the page has been refreshed to a newer revision.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe revision tag on the page now shows v3.6.5 instead of v3.6.4, indicating a newer build. The change does not modify the main content or user-facing features.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a patch-level update to the page's underlying version.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, signaling a new site update release.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a software update rather than a change to study details.SummaryDifference0.0%

- Check88 days agoChange DetectedA new publication citation has been added to the study record, detailing the safety analysis of the FRESCO-2 trial in Oncologist (2025). The citation lists Eng C et al. and the article title related to fruquintinib versus placebo in refractory metastatic colorectal cancer.SummaryDifference0.0%

Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.